Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You
Read more
Blog
On July 9, 2024 | By The Velsera Clinical and Compliance Team
Velsera Publications
On July 5, 2024 | By The Velsera Clinical and Compliance Team
Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence
Read more
News
On June 28, 2024 | By The Velsera Clinical and Compliance Team
Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey
Read more
News
On June 27, 2024 | By The Velsera Clinical and Compliance Team
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus
Read more
Blog
On June 20, 2024 | By The Velsera Clinical and Compliance Team
Navigating your molecular lab’s test selection and development over the next two years
Read more
News
On June 3, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
Read more
Blog
On May 21, 2024 | By Bojana Smiljanic
Unravelling Cellular Complexity: Exploring 3D Genome Structure and DNA Methylation with the snM3C Pipeline
Read more
Blog
On May 14, 2024 | By The Velsera Clinical and Compliance Team
Four Years, Five Stages: the FDA’s Final Rule on LDTs
Read more
News
On April 4, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
Read more
Video
On April 3, 2024 | By The Velsera Clinical and Compliance Team
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data
Read more
News
On March 5, 2024 | By The Velsera Clinical and Compliance Team
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Read more
Video
On February 29, 2024 | By The Velsera Clinical and Compliance Team
State of the Union: NGS Reimbursement
Read more